Skip navigation

Pharma's Market

PHARMA WATCH LIST
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 23279705
Expiration DateTime: 2/10/2012 5:52:05 AM

SPECIAL REPORT


Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 32984624

MOST SHARED


Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 31330905
Expiration DateTime: 2/10/2012 5:51:45 AM

Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 23452000
Expiration DateTime: 2/10/2012 5:51:40 AM

Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 23452764
Expiration DateTime: 2/10/2012 5:51:24 AM

PHARMA'S MARKET VIDEO

» More

Current DateTime: 05:50:57 10 Feb 2012
LinksList Documentid: 31171988
Expiration DateTime: 2/10/2012 5:51:08 AM

RSS FEED

» Help

Current DateTime: 05:50:58 10 Feb 2012
LinksList Documentid: 31171995

Drug Sales Reps And Doctors: The Real "Pharma's Market"

Published: Monday, 5 Nov 2007 | 10:40 AM ET
Text Size
By: Mike Huckman
Reporter

CNBC.com

As I begin my vacation, I wanted to tell you about a story I did that's airing while I'm away on the new edition of CNBC's "Business Nation" this Wednesday (November 7th) at 9 p and midnight ET. It's about the increasingly strained relationship between drug sales reps and doctors.

Who hasn't seen at least one drug salesperson sitting in the waiting room of their doctor's office? This piece aims to clue people in about how the reps do their jobs and influence the physicians to send you home with a prescription for a particular medication.

And it's not just about free pens, pads of paper and dinners at Ruth's Chris Steakhouse. At the risk of sounding like a local TV-news promotional cliche, I think some of the anecdotes and sales tactics will surprise you.

For example, there's a former sales rep who says he and his colleagues used to refer to doctors as "drug whores". That same former rep says one of the doctors he'd call on could be persuaded to write prescriptions for certain drugs depending on which company's sales rep got him sporting event tickets. And on the flip side, a doctor whose practice turned down an estimated half-a-million dollars in annual "rebates" from a major biotech company.

Many of the major drug companies are laying off thousands of sales reps. In the face of declining sales, generic competition, drug development pipeline and commercial disappointments the firms have to cut costs. Analysts have been saying for quite some time that there are way too many sales reps calling on doctors. But tens of thousands of them who are still on the payroll are encountering a growing level of pushback from busy docs and frustrated, prominent med school.

At my suggestion, CNBC bought an ad for the story on www.cafepharma.com to promote it and hopefully generate buzz. The site is primarily geared toward pharma and biotech employees, especially sales reps who are looking for jobs, company insight, to chat and, frankly, spread gossip and rumors. There are already at least a couple of threads that have apparently grown out of the ad which will be on the site for about a week.

I hope it promotes intelligent debate and the show--9p and midnight ET this Wednesday--and that you'll watch.

Questions?  Comments? 

© 2012 CNBC, Inc. All Rights Reserved


Current DateTime: 05:18:53 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 04:15:11 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 04:14:52 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 04:14:52 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters